<p>Gamco Investors INC. ET AL 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第四季度减少了对 CVS Health Corporation (NYSE:CVS - 免费报告) 的持股比例，降幅为 11.6%。该机构投资者在此期间出售了 14,768 股后，持有 112,713 股该药房运营商的股票。根据其最近向 SEC 提交的文件，Gamco Investors INC. ET AL 在 CVS Health 的持股价值为 8,945,000 美元。</p>
<ul>
<li>3 只医疗保健股票将受益于这项重大法案</li>
</ul>
<p>其他几家机构投资者和对冲基金也买卖了该股票的股份。国家养老金服务在第三季度将其在 CVS Health 的持股比例提高了 3.1%。国家养老金服务目前持有 3,999,622 股该药房运营商的股票，价值 301,532,000 美元，此前在上个季度又购买了 119,189 股。Kingsview Wealth Management LLC 在第三季度将其在 CVS Health 的持股比例提高了 316.2%。Kingsview Wealth Management LLC 目前持有 104,432 股该药房运营商的股票，价值 7,873,000 美元，此前在上个季度又购买了 79,340 股。AE Wealth Management LLC 在第三季度将其在 CVS Health 的持股比例提高了 6.2%。AE Wealth Management LLC 目前持有 257,204 股该药房运营商的股票，价值 19,391,000 美元，此前在上个季度又购买了 14,983 股。未来资产全球投资有限公司在第三季度将其在 CVS Health 的持股比例提高了 11.2%。未来资产全球投资有限公司目前持有 225,116 股该药房运营商的股票，价值 16,971,000 美元，此前在上个季度又购买了 22,653 股。最后，财富提升顾问服务有限公司在第三季度将其在 CVS Health 的持股比例提高了 186.6%。财富提升顾问服务有限公司目前持有 396,368 股该药房运营商的股票，价值 30,568,000 美元，此前在上个季度又购买了 258,050 股。机构投资者持有该公司 80.66% 的股票。</p>
<h2>分析师评级变动</h2>
<p>多位股票分析师对 CVS 股票发表了看法。华尔街禅在 5 月 9 日的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。摩根大通在 5 月 12 日的研究报告中将 CVS Health 的目标价从 101.00 美元上调至 111.00 美元，并给予该股票 “超配” 评级。罗伯特·W·贝尔德在 4 月 15 日的研究报告中将 CVS Health 的目标价从 92.00 美元上调至 94.00 美元，并给予该股票 “跑赢大盘” 评级。韦斯评级在 5 月 8 日的研究报告中重申了对 CVS Health 股票的 “持有（c）” 评级。最后，巴克莱在 5 月 7 日的研究报告中将 CVS Health 的目标价从 93.00 美元上调至 101.00 美元，并给予该公司 “超配” 评级。22 位股票研究分析师对该股票给予了买入评级，4 位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 98.08 美元。</p>
<ul>
<li>这只 ETF 证明医疗保健反弹是真实的</li>
</ul>
<p><strong>查看我们关于 CVS 的最新报告</strong></p>
<h2>CVS Health 的内部交易</h2>
<p>在相关消息中，执行副总裁 Tilak Mandadi 于 5 月 8 日星期五出售了 69,551 股该股票。该股票的平均售价为 89.58 美元，总交易额为 6,230,378.58 美元。出售后，该执行副总裁持有 10,133 股公司股票，价值 907,714.14 美元。这代表其持股比例减少了 87.28%。该交易已在向 SEC 提交的文件中披露，相关信息可通过 SEC 网站获取。0.85% 的股票由公司内部人士持有。</p>
<h2>CVS Health 的价格表现</h2>
<ul>
<li>CVS Health 随着收入增长而上涨，股息保持强劲</li>
</ul>
<p>CVS Health 股票在星期三开盘价为 94.18 美元。CVS Health Corporation 的 12 个月低点为 58.50 美元，12 个月高点为 98.43 美元。该股票的 50 日移动平均线为 79.39 美元，200 日移动平均线为 78.76 美元。该公司的流动比率为 0.87，速动比率为 0.66，债务与股本比率为 0.78。该公司的市值为 1201.6 亿美元，市盈率为 41.49，PEG 比率为 0.94，贝塔值为 0.60。</p>
<p>CVS Health (NYSE:CVS - 获取免费报告) 最近在 5 月 6 日星期三发布了其财报。该药房运营商报告本季度每股收益为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。CVS Health 的股本回报率为 11.88%，净利润率为 0.72%。该公司本季度的收入为 1004.3 亿美元，而市场共识预期为 949.9 亿美元。在去年同期，该公司每股收益为 2.25 美元。该公司本季度的收入同比增长 6.2%。CVS Health 已将其 2026 财年的每股收益指导设定为 7.300-7.500。股票研究分析师预计 CVS Health Corporation 本年度将发布 7.44 美元的每股收益。</p>
<h2>CVS Health 宣布分红</h2>
<p>该公司最近还宣布了季度分红，已于 5 月 4 日星期一支付。4 月 23 日的登记投资者获得了每股 0.665 美元的分红。该分红的除息日期为 4 月 23 日。这相当于每年 2.66 美元的分红，收益率为 2.8%。CVS Health 的分红支付比率目前为 117.18%。</p>
<h2>关于 CVS Health 的热门头条</h2>
<p>以下是本周影响 CVS Health 的主要新闻故事：</p>
<ul>
<li>积极情绪：CVS Health 和 WGU 推出了一个在线预药学学位项目，旨在为全国未来的药剂师建立人才储备，这可能有助于解决劳动力短缺问题，并支持 CVS 的零售药房运营。CVS Health(R) 和 WGU 为全国未来药剂师推出在线预药学学位项目</li>
<li>积极情绪：CVS 还支持 EnsembleIQ 的活动，倡导零售药房作为填补医疗空白的一种方式，进一步巩固了 CVS 在社区药房和医疗服务获取中的角色。EnsembleIQ 的 DSN，作为社区药房领域的可信来源，发起支持零售药房填补医疗空白的活动</li>
<li>积极情绪：CVS Health 发布的一项研究显示，许多医疗保险成员在数字健康素养方面存在困难，这支持了公司在数字工具和成员参与方面的投资。CVS Health 研究揭示了医疗保险成员对更高数字健康素养的需求</li>
</ul>
<h2>CVS Health 公司简介</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛州的伍恩索克特，其根源可以追溯到 20 世纪 60 年代初，已发展成为一个综合性处方药、非处方产品、临床服务和健康保险产品的提供者。其运营模式结合了零售药房和店内诊所以及更广泛的药房和健康计划能力。</p>
<p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 诊所和提供扩展临床服务的 HealthHUB 位置。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 CVS Health 更好的股票</li>
<li>HIVE 利用力量进行 AI 转型</li>
<li>深入探讨 NVIDIA 最新的投资组合动态</li>
<li>Brady Corp 进行大规模 AI 驱动的突破</li>
<li>为什么家得宝的抛售可能成为一个巨大机会</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>Gamco Investors INC. 等在第四季度减少了对 CVS Health Corporation 的持股比例 11.6%，出售了 14,768 股。出售后，其持有 112,713 股，估值约为 895 万美元。其他机构投资者也调整了在 CVS Health 的持仓，显著增加了持股。CVS Health 的股票共识评级为 “适度买入”，平均目标价为 98.08 美元</p>

<p>Gamco Investors INC. ET AL lessened its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 11.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 112,713 shares of the pharmacy operator's stock after selling 14,768 shares during the period. Gamco Investors INC. ET AL's holdings in CVS Health were worth $8,945,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Gamco Investors INC. ET AL 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第四季度减少了对 CVS Health Corporation (NYSE:CVS - 免费报告) 的持股比例，降幅为 11.6%。该机构投资者在此期间出售了 14,768 股后，持有 112,713 股该药房运营商的股票。根据其最近向 SEC 提交的文件，Gamco Investors INC. ET AL 在 CVS Health 的持股价值为 8,945,000 美元。</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只医疗保健股票将受益于这项重大法案</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also bought and sold shares of the stock. National Pension Service increased its position in CVS Health by 3.1% during the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator's stock worth $301,532,000 after buying an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC increased its position in CVS Health by 316.2% during the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator's stock worth $7,873,000 after buying an additional 79,340 shares during the last quarter. AE Wealth Management LLC increased its position in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator's stock worth $19,391,000 after buying an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in CVS Health by 11.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator's stock worth $16,971,000 after buying an additional 22,653 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in CVS Health by 186.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator's stock worth $30,568,000 after buying an additional 258,050 shares during the last quarter. Institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金也买卖了该股票的股份。国家养老金服务在第三季度将其在 CVS Health 的持股比例提高了 3.1%。国家养老金服务目前持有 3,999,622 股该药房运营商的股票，价值 301,532,000 美元，此前在上个季度又购买了 119,189 股。Kingsview Wealth Management LLC 在第三季度将其在 CVS Health 的持股比例提高了 316.2%。Kingsview Wealth Management LLC 目前持有 104,432 股该药房运营商的股票，价值 7,873,000 美元，此前在上个季度又购买了 79,340 股。AE Wealth Management LLC 在第三季度将其在 CVS Health 的持股比例提高了 6.2%。AE Wealth Management LLC 目前持有 257,204 股该药房运营商的股票，价值 19,391,000 美元，此前在上个季度又购买了 14,983 股。未来资产全球投资有限公司在第三季度将其在 CVS Health 的持股比例提高了 11.2%。未来资产全球投资有限公司目前持有 225,116 股该药房运营商的股票，价值 16,971,000 美元，此前在上个季度又购买了 22,653 股。最后，财富提升顾问服务有限公司在第三季度将其在 CVS Health 的持股比例提高了 186.6%。财富提升顾问服务有限公司目前持有 396,368 股该药房运营商的股票，价值 30,568,000 美元，此前在上个季度又购买了 258,050 股。机构投资者持有该公司 80.66% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of equities analysts have weighed in on CVS shares. Wall Street Zen raised CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, May 9th. JPMorgan Chase &amp; Co. boosted their price target on CVS Health from $101.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a research report on Tuesday, May 12th. Robert W. Baird boosted their price target on CVS Health from $92.00 to $94.00 and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, April 15th. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of CVS Health in a research report on Friday, May 8th. Finally, Barclays upped their target price on CVS Health from $93.00 to $101.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, May 7th. Twenty-two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $98.08.</p>
<div class="lb-trans"><p>多位股票分析师对 CVS 股票发表了看法。华尔街禅在 5 月 9 日的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。摩根大通在 5 月 12 日的研究报告中将 CVS Health 的目标价从 101.00 美元上调至 111.00 美元，并给予该股票 “超配” 评级。罗伯特·W·贝尔德在 4 月 15 日的研究报告中将 CVS Health 的目标价从 92.00 美元上调至 94.00 美元，并给予该股票 “跑赢大盘” 评级。韦斯评级在 5 月 8 日的研究报告中重申了对 CVS Health 股票的 “持有（c）” 评级。最后，巴克莱在 5 月 7 日的研究报告中将 CVS Health 的目标价从 93.00 美元上调至 101.00 美元，并给予该公司 “超配” 评级。22 位股票研究分析师对该股票给予了买入评级，4 位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 98.08 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这只 ETF 证明医疗保健反弹是真实的</li>
</ul>
</div><p><strong>Check Out Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS 的最新报告</strong></p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的内部交易</h2>
</div><p>In related news, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares of the company's stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.85% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Tilak Mandadi 于 5 月 8 日星期五出售了 69,551 股该股票。该股票的平均售价为 89.58 美元，总交易额为 6,230,378.58 美元。出售后，该执行副总裁持有 10,133 股公司股票，价值 907,714.14 美元。这代表其持股比例减少了 87.28%。该交易已在向 SEC 提交的文件中披露，相关信息可通过 SEC 网站获取。0.85% 的股票由公司内部人士持有。</p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 的价格表现</h2>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 随着收入增长而上涨，股息保持强劲</li>
</ul>
</div><p>CVS Health stock opened at $94.18 on Wednesday. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $98.43. The stock's 50 day moving average is $79.39 and its 200-day moving average is $78.76. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $120.16 billion, a price-to-earnings ratio of 41.49, a PEG ratio of 0.94 and a beta of 0.60.</p>
<div class="lb-trans"><p>CVS Health 股票在星期三开盘价为 94.18 美元。CVS Health Corporation 的 12 个月低点为 58.50 美元，12 个月高点为 98.43 美元。该股票的 50 日移动平均线为 79.39 美元，200 日移动平均线为 78.76 美元。该公司的流动比率为 0.87，速动比率为 0.66，债务与股本比率为 0.78。该公司的市值为 1201.6 亿美元，市盈率为 41.49，PEG 比率为 0.94，贝塔值为 0.60。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. The firm's revenue for the quarter was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts expect that CVS Health Corporation will post 7.44 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 获取免费报告) 最近在 5 月 6 日星期三发布了其财报。该药房运营商报告本季度每股收益为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。CVS Health 的股本回报率为 11.88%，净利润率为 0.72%。该公司本季度的收入为 1004.3 亿美元，而市场共识预期为 949.9 亿美元。在去年同期，该公司每股收益为 2.25 美元。该公司本季度的收入同比增长 6.2%。CVS Health 已将其 2026 财年的每股收益指导设定为 7.300-7.500。股票研究分析师预计 CVS Health Corporation 本年度将发布 7.44 美元的每股收益。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health's dividend payout ratio is currently 117.18%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，已于 5 月 4 日星期一支付。4 月 23 日的登记投资者获得了每股 0.665 美元的分红。该分红的除息日期为 4 月 23 日。这相当于每年 2.66 美元的分红，收益率为 2.8%。CVS Health 的分红支付比率目前为 117.18%。</p>
</div><h2>Trending Headlines about CVS Health</h2>
<div class="lb-trans"><h2>关于 CVS Health 的热门头条</h2>
</div><p>Here are the key news stories impacting CVS Health this week:</p>
<div class="lb-trans"><p>以下是本周影响 CVS Health 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide</li>
<li>Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps</li>
<li>Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：CVS Health 和 WGU 推出了一个在线预药学学位项目，旨在为全国未来的药剂师建立人才储备，这可能有助于解决劳动力短缺问题，并支持 CVS 的零售药房运营。CVS Health(R) 和 WGU 为全国未来药剂师推出在线预药学学位项目</li>
<li>积极情绪：CVS 还支持 EnsembleIQ 的活动，倡导零售药房作为填补医疗空白的一种方式，进一步巩固了 CVS 在社区药房和医疗服务获取中的角色。EnsembleIQ 的 DSN，作为社区药房领域的可信来源，发起支持零售药房填补医疗空白的活动</li>
<li>积极情绪：CVS Health 发布的一项研究显示，许多医疗保险成员在数字健康素养方面存在困难，这支持了公司在数字工具和成员参与方面的投资。CVS Health 研究揭示了医疗保险成员对更高数字健康素养的需求</li>
</ul>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛州的伍恩索克特，其根源可以追溯到 20 世纪 60 年代初，已发展成为一个综合性处方药、非处方产品、临床服务和健康保险产品的提供者。其运营模式结合了零售药房和店内诊所以及更广泛的药房和健康计划能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 诊所和提供扩展临床服务的 HealthHUB 位置。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>HIVE Weaponizes Power for an AI Pivot</li>
<li>A Deep Dive Into NVIDIA’s Latest Portfolio Moves</li>
<li>Brady Corp Wires Up a Massive AI-Powered Breakout</li>
<li>Why Home Depot’s Sell-Off Could Become a Huge Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 CVS Health 更好的股票</li>
<li>HIVE 利用力量进行 AI 转型</li>
<li>深入探讨 NVIDIA 最新的投资组合动态</li>
<li>Brady Corp 进行大规模 AI 驱动的突破</li>
<li>为什么家得宝的抛售可能成为一个巨大机会</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS

Market Beat

GAMCO Investors, Inc.

摩根大通

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Gamco Investors INC. ET AL 出售了 14,768 股西维斯健康公司的股票 $CVS